title: [Possibilities of treatment of external pancreatic fistula].
abstract: Evaluation of the efficacy of sekretolitičeskoj therapy with synthetic analogue of somatostatin, a short-acting oktreotid (group 1) and extended oktreotid-depo (group 2) in 24 patients with external pancreatic fistulas after destructive pancreatitis. Results of clinical studies have shown that against the backdrop of an analogue of somatostatin-depo true healing and purulent-necrotic pancreatic external fistula occurs in less time: average 19 ± 1.8, and 16.2 ± 1.2 day observations, respectively.
authors.forename: D V
authors.initials: DV
authors.lastname: Cherdantsev
authors.forename: O V
authors.initials: OV
authors.lastname: Pervova
authors.forename: V Iu
authors.initials: VIu
authors.lastname: Diatlov
authors.forename: D Sh
authors.initials: DSh
authors.lastname: Kurbanov
mesh_terms: D000328:Adult; D000681:Amylases / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D057186:Comparative Effectiveness Research; D017577:Cutaneous Fistula / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D004304:Dosage Forms; D004359:Drug Therapy, Combination; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage*; D046790:Pancreas, Exocrine / Q000187:drug effects* / Q000378:metabolism; D010185:Pancreatic Fistula / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D010195:Pancreatitis / Q000150:complications; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects
chemical_list: D000900:Anti-Bacterial Agents; D004304:Dosage Forms; D005765:Gastrointestinal Agents; D000681:Amylases; D015282:Octreotide